{Reference Type}: Journal Article
{Title}: Aging and cognitive resilience: Molecular mechanisms as new potential therapeutic targets.
{Author}: Cordeiro A;Gomes C;Bicker J;Fortuna A;
{Journal}: Drug Discov Today
{Volume}: 29
{Issue}: 9
{Year}: 2024 Jul 9
{Factor}: 8.369
{DOI}: 10.1016/j.drudis.2024.104093
{Abstract}: As the global population ages, the need to prolong lifespan and healthspan becomes increasingly imperative. Understanding the molecular determinants underlying cognitive resilience, together with changes during aging and the (epi)genetic factors that predispose an individual to decreased cognitive resilience, open avenues for researching novel therapies. This review provides a critical and timely appraisal of the molecular mechanisms underlying cognitive resilience, framed within a critical analysis of emerging therapeutic strategies to mitigate age-related cognitive decline. Significant insights from both animals and human subjects are discussed herein, directed either toward active pharmaceutical ingredients (drug repositioning or macromolecules), or, alternatively, advanced cellular therapies.